AC Immune Inc (ACIU): Projected Price to Earnings
AC Immune management is focused on developing high-precision tools for the therapy and detection of Parkinson's and Alzheimer's pathologies through strategic alliances. The operating model relies on engaging external certified organizations to conduct drug trials, which minimizes internal costs. The current P/E ratio is 7.00, as clearly demonstrated by this market valuation chart.
Metric breakdowns and analytics for AC Immune Inc (ACIU)
- stock quotes and analyst forecast:
- stock exchange capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
- earnings and market ratios statistics:
ACIU - Net Profit|Projected Future Earnings AC Immune|ACIU - Price to Earnings Ratio|Forward P/E Multiple AC Immune Corp|ACIU - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio AC Immune S.A.|ACIU - Operating profit EBITDA|Earnings per share for the last twelve months AC Immune|ACIU - Earnings per share for the last 12 months|Quarterly EPS earnings growth acimmune.com|ACIU - Earnings per share growth rate in current year|Expected earnings per share growth for next year AC Immune
Comprehensive company analysis:ACIU AC Immune SA
AC Immune is recruiting leading neurobiologists to develop Alzheimer's disease therapies. By analyzing the company's current forward P/E, an investor can determine the business's market value relative to its projected earnings. This metric aggregates the weighted probabilities of future income, reflecting the market's level of optimism. A deviation from the mean signals that the asset is overheated, while low indicators necessitate caution to avoid investing in a loss-making business.
Who AC Immune competes with
Forward P/E Multiple BIIB|Projected Price to Earnings Neurocrine NBIX|Regencell - Projected Price to Earnings|Future Price to Earnings Multiple AXSM|ACADIA Pharmaceuticals - Forward P/E Multiple|Market Cap to Projected Earnings xenon-pharma.com XENE|Viking Therapeutics, Inc. (VKTX) - Future Price to Earnings|Projected Price to Earnings Supernus Pharmaceuticals, Inc.|Future Price to Earnings Catalyst Pharmaceuticals Inc|Projected Price to Earnings Denali Corp (DNLI)|Projected Price to Earnings HRMY (Harmony Biosciences)|Forward P/E Multiple biohavenpharma.com (BHVN)|Future Price to Earnings Amylyx Pharmaceuticals, Inc. AMLX|TRVI: Price to Future Earnings Ratio|Praxis Medicines - Forward P/E Multiple|Projected Price to Earnings Ratio Anavex Life Sciences Corp|CBLL: Forward P/E Multiple|Prothena (PRTA) - Forward P/E Multiple|ALEC (Alector Inc.) - Forward P/E Multiple|Projected Price to Earnings Annexon Biosciences (ANNX)|Forward P/E Multiple OMER|Market Cap to Projected Earnings Neurogene Therapeutics|Voyager Therapeutics - Projected Price to Earnings|Forward P/E Multiple neumoratx.com NMRA|SCLX - Future Price to Earnings|TVGN (Tevogen Bio Holdings Inc.) - Price to Future Earnings Ratio|ACOG: Forward P/E Multiple|Projected Price to Earnings Ratio Cognition Therapeutics Inc. (CGTX)|Projected Price to Earnings IKT|Forward P/E Multiple cassavasciences.com|Future Price to Earnings Assertio Holdings, Inc. (ASRT)|COYA (coyatherapeutics.com) - Future Price to Earnings Multiple|Future Price to Earnings Vistagen VTGN|Ovid Therapeutics Inc (OVID) - Projected Price to Earnings Ratio|Acumen Pharmaceuticals - Forward P/E Multiple|CRVO - Forward P/E Multiple|ATHE: Forward P/E Multiple|Projected Price to Earnings Clene|Projected Price to Earnings PEPG|JUNS: Future Price to Earnings Multiple|Forward P/E Multiple RLMD|Market Cap to Projected Earnings annovisbio.com|Future Price to Earnings Grace Therapeutics GRCE|AIFF - Projected Price to Earnings|KLTO - Future Price to Earnings|NeuroSense Therapeutics (NRSN) - Projected Price to Earnings|RVPH (Reviva Pharmaceuticals) - Projected Price to Earnings|MetaVia (MTVA) - Forward P/E Multiple|Future Price to Earnings NeurAxis|Price to Future Earnings Ratio HSDT (Helius Medical Technologies Inc.)|Forward P/E Multiple PASG|NEUP - Projected Price to Earnings Ratio|Forward P/E Multiple NERV (Minerva Neurosciences)|Forward P/E Multiple athira.com ATHA|Addex Therapeutics Ltd - Forward P/E Multiple|Alzamend Neuro, Inc. (ALZN) - Projected Price to Earnings|CYCN: Forward P/E Multiple|PTIX - Market Cap to Projected Earnings|Projected Price to Earnings KTTA|Forward P/E Multiple Cortigent Medical|Future Price to Earnings Avenue Therapeutics, Inc. (ATXI)|Brainstorm Cell Therapeutics Inc. - Price to Future Earnings Ratio|Forward P/E Multiple CARA (Cara Therapeutics, Inc)|Chromocell (CHRO) - Projected Price to Earnings Ratio|ELYM: Projected Price to Earnings|ITCI - Forward P/E Multiple|Longboard Pharmaceuticals, Inc. (LBPH) - Future Price to Earnings|Marinus Pharmaceuticals Inc - Future Price to Earnings Multiple|Future Price to Earnings NKGen|Projected Price to Earnings Ratio NeuroBo Pharma NRBO|Forward P/E Multiple SAGE|Forward P/E Multiple synaptogen.com (SNPX)|Forward P/E Multiple TRVN (Trevena)|VIGL - Projected Price to Earnings|WENA: Projected Price to Earnings|Future Price to Earnings Multiple CERE (Cerevel Corp)
